Establishes the "New York regenerative medicine advancement and patient protection act" to build framework for regenerative medicine and cell-based therapies; creates patient protections and disclosure requirements; authorizes limited physician use of qualifying regenerative medicine protocols; creates a regenerative medicine registry; establishes the New York regenerative medicine innovation program.
- Chamber
- House
- Introduced
- May 11, 2026
- Last action
- May 11, 2026 — REFERRED TO HEALTH
- Session
- 2025-2026
- Momentum
- 26 · Low